JAGX Jaguar Health Inc: Accounting Value per Share

Graphic logo of Jaguar Health, Inc. (JAGX)

A stable trend in book value per share confirms that Jaguar Health, Inc. (JAGX) is protecting its market share in the gastrointestinal therapy segment. Growth is supported by inelastic demand for Mytesi and a unique pricing policy. Patents for plant raw material extraction create a significant barrier to entry for competitors. Currently, this metric holds around 20.41, indicating a high level of asset coverage.

Jaguar Health Inc (JAGX): Share Book Value from 07/04/2022 to 10/29/2026

jaguar.health - analytical breakdowns and key metrics (JAGX)

- price and consensus price forecast:
Stock Price Jaguar Animal Health|JAGX - Analyst Target Range
- market capitalization data:
Market Valuation Jaguar Health, Inc.|JAGX - Business Value
- book capitalization data:
Net Assets per Single Share Jaguar Health|JAGX - Net Asset Value|Market Capitalization to Book Value Ratio jaguar.health|JAGX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Jaguar Health, Inc.|JAGX - Long-Term Debt to Capital|Short-Term Debt to Equity Jaguar Health|JAGX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Jaguar Health, Inc.|JAGX - Company Long-Term Liabilities|Company Short-Term Debts Jaguar Health
Fundamental company valuation:Jaguar Animal Health - JAGX
Manufactured products of Jaguar Health

When selecting an issuer, fundamental analysis relies on multiples that reflect the intrinsic value of a business relative to market quotes. This metric measures the portion of net equity attributable to a single share, which for Jaguar Health, Inc. (JAGX), given its strategy of monopolizing the botanical diarrhea therapy niche, confirms the actual volume of assets recorded in the final book value per share.

Competitors of Jaguar Health, Inc. (JAGX)

Book Value per Share PHAT|Terns Corp (TERN) - Book Value of One Share|Accounting Value per Share ironwoodpharma.com|CURX (Curanex Pharmaceuticals) - Equity per Share|Net Assets per Single Share Immuron Ltd IMRN|Share Book Value Evoke Pharma Inc.|Entero Therapeutics, Inc. (ENTO) - Book Value per Share|Accounting Value of a Share redhillbio.com (RDHL)|Book Value per Share PALI (Palisade Bio, Inc.)|bioratherapeutics.com - Book Value per Share|Net Assets per Single Share Morphic (MORF)